PhaseBio Pharmaceuticals
(NASDAQ:PHAS)
$0.8644
0.0824[10.54%]
Last update: 10:01AM
Day Range0.8 - 0.8752 Wk Range0.5 - 2.7Open / Close0.8 / -Float / Outstanding40.5M / 49.9M
Vol / Avg.27K / 244.6KMkt Cap43.1MP/E-50d Avg. Price1.1
Div / Yield-Payout Ratio-Total Float40.5MEPS-0.34

PhaseBio Pharmaceuticals Stock (NASDAQ:PHAS), Quotes and News Summary

PhaseBio Pharmaceuticals Stock (NASDAQ: PHAS)

Day Range0.8 - 0.8752 Wk Range0.5 - 2.7Open / Close0.8 / -Float / Outstanding40.5M / 49.9M
Vol / Avg.27K / 244.6KMkt Cap43.1MP/E-50d Avg. Price1.1
Div / Yield-Payout Ratio-Total Float40.5MEPS-0.34
Sector: Health Care.Industry: Biotechnology
PhaseBio Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications. The lead product candidate of the company is PB2452, which is a novel reversal agent for the antiplatelet drug ticagrelor, used for the treatment of patients experiencing major bleeding or those who require urgent surgery. It is also developing PB1046 which is a fusion protein for the treatment of pulmonary arterial hypertension. The company is also developing its preclinical product candidate, PB6440, for treatment-resistant hypertension.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-09
REV
Q2 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV208.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

PhaseBio Pharmaceuticals Questions & Answers

Q
How do I buy PhaseBio Pharmaceuticals (PHAS) stock?
A

You can purchase shares of PhaseBio Pharmaceuticals (NASDAQ: PHAS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are PhaseBio Pharmaceuticals's (PHAS) competitors?
Q
What is the target price for PhaseBio Pharmaceuticals (PHAS) stock?
A

The latest price target for PhaseBio Pharmaceuticals (NASDAQ: PHAS) was reported by Needham on Monday, August 15, 2022. The analyst firm set a price target for 8.00 expecting PHAS to rise to within 12 months (a possible 825.50% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for PhaseBio Pharmaceuticals (PHAS)?
A

The stock price for PhaseBio Pharmaceuticals (NASDAQ: PHAS) is $0.8644 last updated Today at September 27, 2022, 2:01 PM UTC.

Q
Does PhaseBio Pharmaceuticals (PHAS) pay a dividend?
A

There are no upcoming dividends for PhaseBio Pharmaceuticals.

Q
When is PhaseBio Pharmaceuticals (NASDAQ:PHAS) reporting earnings?
A

PhaseBio Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q
Is PhaseBio Pharmaceuticals (PHAS) going to split?
A

There is no upcoming split for PhaseBio Pharmaceuticals.

Q
What sector and industry does PhaseBio Pharmaceuticals (PHAS) operate in?
A

PhaseBio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.